生物智造
Search documents
朗坤科技:将聚焦生物智造核心技术研发,持续拓展高附加值产品领域
Sou Hu Cai Jing· 2025-11-25 01:20
Core Viewpoint - The company, Langkun Technology, is addressing investor concerns regarding project completion timelines, current sales of biodiesel, and its long-term vision to become a world-class bio-manufacturing enterprise [1] Group 1: Project and Sales Information - The company has been asked about the completion timeline for the Fangshan and Tongzhou projects, which are expected to be completed by 2026 [1] - Current sales figures for biodiesel were not disclosed, with the company indicating that specific details will be provided in future reports or announcements [1] Group 2: Long-term Vision and Strategic Response - Langkun Technology aims to focus on core technology research in bio-manufacturing, expand into high-value product areas, optimize production capacity and supply chain, and enhance talent development to improve market competitiveness [1] - In response to the Shenzhen government's plan for a 7 trillion yuan increase in market capitalization for listed companies by 2027, the company plans to actively engage in its main business, improve operational performance, and enhance communication with investors to align its value and market capitalization [1]
朗坤科技:聚焦生物智造核心技术研发
Sou Hu Cai Jing· 2025-11-25 01:12
Core Viewpoint - Longkun Technology (301305) is actively addressing investor concerns regarding project completion timelines, sales of biodiesel, and its strategic vision to become a world-class bio-manufacturing enterprise, while also responding to local government initiatives for market capitalization growth by 2027 [1] Group 1: Project and Sales Information - The company has been asked about the completion timeline for the Fangshan and Tongzhou projects, which are expected to be completed by 2026 [1] - Current sales figures for biodiesel were not disclosed, with the company indicating that specific details will be provided in future reports [1] Group 2: Strategic Vision and Government Response - Longkun Technology aims to focus on core technology research in bio-manufacturing, expand into high-value product areas, optimize production capacity and supply chain, and enhance talent development to improve market competitiveness [1] - In response to the Shenzhen government’s plan for a 7 trillion yuan increase in market capitalization for listed companies by 2027, the company plans to deepen its core business, improve operational performance, and enhance investor communication to align its value and market capitalization [1]